Draig Therapeutics
Draig Therapeutics develops neuropsychiatric medicines.
$65MSeries B
Role not disclosedActivity from announced rounds
Draig Therapeutics develops neuropsychiatric medicines.
Develops inhaled therapies for severe respiratory diseases